Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells

Molecular and Cellular Biology

Volumn 18, Issue 12, 1998, Pages 7095-7105

  Kustikova, Olga ^a,c   Kramerov, Dmitrii ^a,d   Grigorian, Mariam ^a   Berezin, Vladimir ^b   Bock, Elisabeth ^b   Lukanidin, Eugene ^a   Tulchinsky, Eugene ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c INSTITUTE OF GENE BIOLOGY   (Russian Federation)

^d RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TRANSCRIPTION FACTOR AP 1;

ADENOCARCINOMA; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CARCINOGENESIS; CELL MOTILITY; CELL STRUCTURE; EPITHELIUM TUMOR; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALIA;

EID: 0031756337     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.12.7095     Document Type: Article

References (88)

1. Albini, A., Y. Iwamoto, H. K. Kleinman, G. R. Martin, S. A. Aaronson, J. M. Kozlowsky, and R. N. McEvan. 1987. A rapid in vivo assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239-3245.
2. Andreasen, P. A., L. Kjøller, L. Christensen, and M. J. Duffy. 1997. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72:1-22.
3. Andrews, N. C., and D. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
4. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
5. Arts, J., I. Herr, M. Lansink, P. Angel, and T. Kooistra. 1997. Cell type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro. Nucleic Acids Res. 25:311-317.
6. Bahler, D. W., E. M. Lord, S. J. Kennel, and P. K. Koran. 1984. Heterogeneity and clonal variation related to cell surface expression of a mouse lung tumor-associated antigen quantified using flow cytometry. Cancer Res. 144: 3317-3323.
7. Barnett, S. C., and S. A. Eccles. 1984. Studies of mammary carcinoma metastasis in a mouse model system. I. Derivation and characterization of cells with different metastatic properties during tumor progression in vivo. Clin. Exp. Metast. 2:15-36.
8. Basset-Séguin, N., P. Demoly, J. P. Moles, A. Tesniéres, C. Gauthier-Rouviére, S. Richard, J. M. Blanchard, and J. J. Guilhou. 1994. Comparative analysis of cellular and tissular expression of c-fos in human keratinocytes: evidence of its role in cell differentiation. Oncogene 9:765-771.
9. Behlin, D., J.-D. Vassalli, C. Combepine, F. Godeou, J. Nagamine, E. Reich, H. P. Kocher, and R. M. Duvoisin. 1985. Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur. J. Biochem. 148:225-232.
10. Bengal, E., L. Ransone, R. Scharfmann, V. T. Dwark, S. J. Tapscott, H. Weintraub, and I. M. Verma. 1992. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 68:507-519.
11. Bergers, G., P. Graninger, S. Braselmann, C. Wrighton, and M. Busslinger. 1995. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol. 15:3748-3758.
12. Birchmeier, W., and J. Behrens. 1994. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta 1198:11-26.
13. Blanar, M. A., and W. J. Rutter. 1992. Interaction cloning: identification of a helix-loop helix zipper protein that interacts with c-Fos. Science 256:1014-1017.
14. Bossy-Wetzel, E., L. Bakiri, and M. Yaniv. 1997. Induction of apoptosis by the transcription factor c-Jun. EMBO J. 16:1695-1709.
15. Breatnach, R., L. M. Matrisian, M. C. Gesnel, A. Staub, and P. Leroy. 1987. Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene. Nucleic Acids Res. 15:1139-1151.
16. Chiapetta, G., A. Bandiera, M. T. Berlingieri, R. Visconti, G. Manfioletti, S. Battista, F. J. Martinez-Tello, M. Santoro, V. Giancotti, and A. Fusco. 1995. The expression of the high mobility group HMG I(Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 10: 1307-1314.
17. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidiniun thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
18. Clark, I. M., A. D. Rowan, D. R. Edwards, T. Bech-Hansen, D. A. Mann, M. J. Bahr, and T. E. Cawston. 1997. Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem. J. 324:611-617.
19. Cohen, D. R., and T. Curran. 1988. fra-1: a serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen. Mol. Cell. Biol. 8:2063-2069.
20. Dunn, G. A. 1983. Characterizing a kinesis response: time averaged measures of cell speed and directional persistence, p. 14-33. In H. Keller, G. O. Till, and A. Abor (ed.) Leucocyte locomotion and chemotaxis. Birkhauser Verlag, Basel, Switzerland.
21. Ebralidze, A., E. Tulchinsky, M. Grigorian, A. Afanasjeva, V. Senin, E. Revazova, and E. Lukanidin. 1989. Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca-binding protein family. Genes Dev. 3:1086-1093.
22. Fialka, I., H. Schwarz, E. Reichmann, M. Oft, M. Busslinger, and H. Beug. 1996. The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions. J. Cell Biol. 132:1115-1132.
23. Fish, E. M., and B. A. Molitoris. 1994. Alterations in epithelial polarity and the pathogenesis of disease states. N. Engl. J. Med. 330:1580-1588.
24. Ford, H. L., M. M. Salim, R. Chakravarty, V. Aluiddin, and S. B. Zain. 1995. Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line. Oncogene 11:2067-2075.
25. Funk, M., B. Poensgen, W. Graulich, V. Jérome, and R. Müller. 1997. A novel transformation-relevant activation domain in Fos proteins. Mol. Cell. Biol. 17:537-544.
26. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
27. Gossen, M., S. Freundlieb, G. Bender, G. Müller, W. Hillen, and H. Bujard. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769.
28. Grigoriadis, A. E., Z.-Q. Wang, M. G. Cecchini, W. Hoffstetter, R. Felix, H. A. Fleisch, and E. F. Wagner. 1994. cFos: a key regulator of osteoclastmacrophage lineage determination and bone remodelling. Science 266:443-447.
29. Gruda, M. C., K. Kovary, R. Metz, and R. Bravo. 1994. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 9:2537-2547.
30. Hai, T., and T. Curran. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88:3720-3724.
31. Hendrix, M. J. C., E. A. Seftor, Y.-W. Chu, K. T. Trevor, and R. E. B. Seftor. 1996. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev. 15:507-525.
32. Hennigan, R. F., K. L. Hawker, and B. W. Ozanne. 1994. Fos-transformation activates genes associated with invasion. Oncogene 9:3591-3600.
33. Himelstein, B. P., E. J. Lee, H. Sáto, M. Seiki, and R. J. Muschel. 1997. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene 14:1995-1998.
34. Hirai, S.-I., R.-P. Ryseck, F. Mechta, R. Bravo, and M. Yaniv. 1989. Characterization of junD: a new member of the jun proto-oncogene family. EMBO J. 8:1433-1439.
35. Hu, E., E. Mueller, S. Oliviero, V. E. Papaioannou, R. Johnson, and B. M. Spiegelman. 1994. Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J. 13:3094-3103.
36. Jäättelä, M., H. Mouritzen, F. Elling, and L. Bastholm. 1996. A20 zinc finger protein inhibits TNF and IL-1 signaling. J. Immunol. 156:1166-1173.
37. Jehn, B., E. Costello, A. Marti, N. Keon, R. Deane, F. Li, R. R. Friis, P. H. Burry, F. Martin, and R. Jaggi. 1992. Overexpression of Mos, Ras, Src, and Fos inhibits mouse mammary epithelial cell differentiation. Mol. Cell Biol. 12:3890-3902.
38. Johnson, K. R., D. A. Lehn, T. S. Elton, P. J. Barr, and R. Reeves. 1988. Complete murine cDNA sequence, genomic structure and tissue expression of the high mobility group protein HMG I(Y). J. Biol. Chem. 263:18338-18342.
39. Johnson, S. J., B. van Lingen, V. E. Papaioannou, and B. M. Spiegelman. 1993. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev. 7:1309-1317.
40. Jooss, K. U., M. Funk, and R. Müller. 1994. An autonomous N-terminal transactivation domain in Fos protein plays a crucial role in transformation. EMBO J. 13:1467-1475.
41. Jooss, K. U., and R. Müller. 1995. Deregulation of genes encoding microfilament-associated proteins during Fos-induced morphological transformation. Oncogene 10:603-608.
42. Kataoka, K., K. T. Fujiwara, M. Noda, and M. Nishizawa. 1994. MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun. Mol. Cell. Biol. 14:7581-7591.
43. Keeton, M. R., S. A. Curriden, A.-J. van Zonneveld, and D. J. Loskutoff. 1991. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor β. J. Biol. Chem. 266:23048-23052.
44. Kerppola, T. K., and T. Curran. 1996. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun. Oncogene 9:675-684.
45. Kerr, L. D., J. T. Holt, and L. M. Matrisian, 1988. Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 242:1424-1427.
46. Kovary, K., and R. Bravo. 1991. The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11:4466-4472.
47. 1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol. Cell. Biol. 12:5015-5023.
48. Lamb, R. F., B. W. Ozanne, C. Roy, L. McGarry, C. Stipp, P. Mangeat, and D. G. Jay. 1997. Essential functions of ezrin in maintenance of cell shape and lamellopodial extension in normal and transformed fibroblasts. Curr. Biol. 7: 682-688.
49. Lauffenburger, D. A., and A. F. Horwitz. 1996. Cell migration: a physically integrated molecular process. Cell 84:359-369.
50. Lauffenburger, D. A., and J. J. Linderman. 1993. Receptors. Models for binding, trafficking and signalling. Oxford University Press, Oxford, United Kingdom.
51. LeBowitz, J. H., T. Kobayashi, L. Staudt, D. Baltimore, and P. A. Sharp. 1988. Octamer-binding proteins from B or HeLa cells stimulate transcription of the immunoglobulin heavy chain promoter in vitro. Genes Dev. 2:1227-1237.
52. Lee, H.-Y., J. Chaudhary, G. L. Walsh, W. K. Hong, and J. M. Kurie. 1998. Suppression of c-Fos gene transcription with malignant transformation of human bronchial epithelial cells. Oncogene 16:3039-3046.
53. Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741-752.
54. Lengyel, E., H. Wang, E. Stepp, J. Juarez, Y. Wang, W. Doe, C. M. Pfarr, and D. Boyd. 1996. Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene. J. Biol. Chem. 271:23176-23184.
55. Lord, K. A., A. Abdollahi, B. Hoffman-Liebermann, and D. A. Liebermann. 1993. Proto-oncogenes of the Fos/Jun family of transcription factors are positive regulators of myeloid differentiation. Mol. Cell. Biol. 13:841-851.
56. Mechta, F., D. Lallemand, C. M. Pfarr, and M. Yaniv. 1997. Transformation by ras modifies AP-1 composition and activity. Oncogene 14:837-847.
57. Mumberg, D., F. C. Lucibello, M. Schuermann, and R. Müller. 1991. Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins. Genes Dev. 5:1212-1223.
58. Nakabeppu, Y., and D. Nathans. 1991. A naturally occuring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64:751-759.
59. Nerlov, C., P. Rorth, F. Blasi, and M. Johnsen. 1991. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6:1583-1592.
60. Nishina, H., H. Sato, T. Suzuki, M. Sato, and H. Iba. 1990. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc. Natl. Acad. Sci. USA 87:3619-3623.
61. Nomura, S., B. L. Hogan, A. J. Wills, J. K. Heath, and D. R. Edwards. 1989. Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA. Development 105:575-583.
62. Okada, H., T. M. Danoff, R. Kallury, and E. G. Neilson. 1997. Early role of Fsp1 in epithelial-mesenchymal transformation. Am. J. Physiol. 273:563-574.
63. Olson, L., and J. Forchhammer. 1984. Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity. Proc. Natl. Acad. Sci. USA 81:3389-3393.
64. Pognonec, P., K. E. Boulukos, C. Aperlo, M. Fujimoto, H. Ariga, A. Nomoto, and H. Kato. 1997. Cross family interaction between the bHLHZip USF and bZIP Fra1 proteins results in down-regulation of AP-1 activity. Oncogene 14: 2091-2098.
65. Preston, G. A., T. T. Lyon, Y. Yin, J. E. Lang, G. Solomon, L. Annab, D. G. Srinivasan, D. A. Alcorta, and J. C. Barret. 1996. Induction of apoptosis by c-Fos protein. Mol. Cell. Biol. 16:211-218.
66. Ram, G. T., R. Reeves, and H. L. Hosick. 1993. Elevated high motility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res. 53:2655-2660.
67. Reichmann, E., H. Schwarz, E. M. Deiner, I. Leitner, M. Eilers, J. Berger, M. Busslinger, and H. Beug. 1992. Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71:1103-1116.
68. Ringwald, M., R. Schuh, D. Vestweber, H. Eistetter, F. Lottspeich, J. Engel, R. Doelz, F. Jahnig, J. Epplen, S. Mayer, C. Müller, and R. Kemler. 1987. The structure of cell adhesion molecule uvomorulin. Insights into the molecular mechanism of Ca-dependent cell adhesion. EMBO J. 6:3647-3653.
69. Rutberg, S. E., E. Saez, A. Glick, A. A. Dlugosz, B. M. Spiegelman, and S. H. Yuspa. 1996. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. Oncogene 13:167-176.
70. Ryseck, R.-P., and R. Bravo. 1991. c-Jun, JunB and JunD differ in their binding affinities to AP-1 and CRE consensus sequences: effect of Fos proteins. Oncogene 6:533-542.
71. Saksela, K., and D. Baltimore. 1993. Negative regulation of immunoglobulin kappa light-chain gene transcription by a short sequence homologous to the murine B1 repetitive element. Mol. Cell. Biol. 13:3698-3705.
72. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
73. Savagner, P., B. Boyer, A. M. Vallès, J. Jouanneau, K. M. Yamada, and J.-P. Thiery. 1994. Modulations of the epithelial phenotype during embryogenesis and cancer progression, p. 229-249. In R. Dickson and M. Lippman (ed.), Mammary tomorogenesis and malignant progression. Kluwer Academic, Norwell, Mass.
74. Schreiber, M., C. Poirier, A. Franchi, R. Kurzbauer, J.-L. Guenet, G. F. Carle, and E. F. Wagner. 1997. Structure and chromosomal assignment of the mouse fra-1 gene, and its exclusion as a candidate gene for oc (osteosclerosis). Oncogene 15:1171-1178.
75. Schuermann, M., G. Hennig, and R. Müller. 1993. Transcriptional activation and transformation by chimaeric Fos-estrogen receptor proteins: altered properties as a consequence of gene fusion. Oncogene 8:2781-2790.
76. Senin, V. M., A. M. Buntsevich, A. V. Afanasyeva, and N. S. Kiseleva. 1983. A new line of murine carcinosarcoma. Exp. Oncol. USSR 5:35-39. (In Russian.)
77. Senin, V. M., A. M. Ivanov, A. V. Afanasjeva, and A. M. Buntsevich. 1984. New organospecific metastatic transplanted tumors of mice and their use for studying laser effect on dissemination. Vestnik USSR Acad. Med. Sci. 5:85-91. (In Russian.)
78. Sonnenberg, A., H. Daams, J. Calafat, and J. Hilgers. 1984. In vitro differentiation and progression of mouse mammary tumor cells. Cancer Res. 46: 5913-5922.
79. Suzuki, T., H. Okuno, T. Yoshido, T. Endo, H. Nishina, and H. Iba. 1991. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res. 19:5537-5542.
80. Thanos, D., and T. Maniatis. 1992. The high mobility group protein HMG I (Y) is required for NF-κB-dependent induction of the human IFNβ gene. Cell 71:777-789.
81. Thanos, D., and T. Maniatis. 1995. Virus induction of human IFNb gene expression requires the assembly of an enhanceosome. Cell 83:1091-1100.
82. Tulchinsky, E. M., G. P. Georgiev, and E. M. Lukanidin. 1996. Novel AP-1 binding site created by DNA-methylation. Oncogene 12:1737-1745.
83. Vallone, D., S. Battista, G. M. Pierantoni, M. Fedele, L. Casalino, M. Santoro, G. Viglietto, A. Fusco, and P. Verde. 1997. Neoplastic transformation of rat thyroid cells requires the JunB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J. 16:5310-5321.
84. Walmod, P. S., A. Foley, A. Berezin, U. Ellerbeck, H. Nau, E. Bock, and V. Berezin. Cell motility is inhibited by the antiepileptic compound valproic acid and its teratogenic analogues. Submitted for publication.
85. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442.
86. Wilhelm, S. M., I. E. Collier, B. L. Marmer, A. Z. Eizen, G. A. Grant, and G. I. Goldberg. 1989. SV-40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264:17213-17221.
87. Wisdom, R., and I. M. Verma. 1993. Transformation by Fos proteins requires a C-terminal transactivation domain. Mol. Cell. Biol. 13:7429-7438.
88. Zeheb, R., and T. D. Gelehrter. 1988. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1. Gene 73:459-468.